Please try another search
The investment seeks long-term capital appreciation by investing primarily in common stocks of emerging market country issuers. The fund will invest primarily in common stocks but also may invest in other types of equity securities, including preferred stock. Under normal circumstances, it invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of issuers. The fund may also invest in securities of issuers located in industrialized countries.
Name | Title | Since | Until |
---|---|---|---|
Fanesca Young | Portfolio Manager | 2023 | Now |
Biography | Fanesca Young, Ph.D., CFA, Senior Vice President, Director, Equity Portfolio Management, serves as lead Portfolio Manager. Prior to joining Acadian, she was head of global systematic equities at GIC Private Ltd. Prior to that, she was managing director and director of quantitative research at Los Angeles Capital Management. Ms. Young is also a member of the editorial boards of the Financial Analyst Journal and the Journal of Systematic Investing, as well as a member of the Q Group's program committee. She earned a Ph.D. in statistics from Columbia University and an M.Phil. and an M.A. in statistics from Columbia University. She also holds a B.A. in mathematics from the University of Virginia. She is a CFA charterholder. | ||
Brendan O. Bradley | Executive Vice President, Chief Investment Officer | 2013 | Now |
Biography | Brendan joined Acadian in 2004 and is the firm’s Chief Investment Officer. Brendan previously served as Director of Portfolio Management, overseeing portfolio management policy, and also as the Director of Acadian’s Managed Volatility strategies. Brendan is a member of several oversight committees at Acadian, including the Board of Managers, Executive Management Team, Executive Committee, and Responsible Investing Committee. Prior to Acadian, Brendan was a vice president at Upstream Technologies, where he designed and implemented investment management systems and strategies. | ||
Ryan D. Taliaferro | Senior Vice President, Director, Investment Strategies | 2018 | 2024 |
Biography | Ryan joined Acadian in 2011 and currently serves as director of investment strategies. | ||
Asha Mehta | Senior Vice President, Portfolio Manager | 2009 | 2019 |
Biography | Asha joined Acadian in 2007 and is the lead portfolio manager and director of responsible investing. Prior to joining Acadian, Asha worked as an investment banker at Goldman Sachs and at Johnson & Johnson in a strategy role. Early in her career, she conducted microfinance lending in India. Asha holds an M.B.A. with Honors from The Wharton School (University of Pennsylvania) and undergraduate degrees from Stanford University. Asha is a CFA charterholder and a Board Member of CFA Society Boston.She was named one of the Top 10 Women in Asset Management by Money Management Executive in 2016. | ||
Brian K. Wolahan | Senior Vice President, Senior Portfolio Manager | 1994 | 2019 |
Biography | Brian joined Acadian in 1990. Prior to his current role as senior portfolio manager, he served as director of portfolio management, overseeing portfolio management policy as well as co-director of Research, responsible for developing and applying investment techniques to evaluate markets and securities. Before joining Acadian, Brian worked in systems planning at Bank of New England and as a senior systems analyst at Mars Incorporated. Brian obtained an M.S. in management from MIT and a B.S. in accounting from Lehigh University. He is a CFA charterholder and a member of CFA Society Boston. | ||
John R. Chisholm | Co-Chief Executive Officer | 1994 | 2019 |
Biography | John R. Chisholm, CFA – Co-Chief Executive Officer, Co-Chief Investment Officer. John Chisholm currently serves as Acadian’s co-chief executive officer, as well as co-chief investment officer. He served as Acadian’s sole CIO from 1998 to 2017, where he oversaw Acadian’s investment process and Investment Team, and directed Acadian's portfolio management and research. Prior to co-founding Acadian in 1987, John served as a systems engineer at Draper Laboratories, and as an analyst for the International Asset Management Department at the State Street Bank and Trust Company (now SSgA). | ||
Ronald D. Frashure | Chief Executive Officer | 1993 | 2015 |
Biography | Ron joined Acadian in March 1988. In addition to his role as President and Chief Executive Officer, he works closely with clients on asset allocation and investment policy issues. Earlier, he spent seventeen years serving as senior equity portfolio manager and director of asset allocation at the Putnam Companies. | ||
Qi R. Zeng | Portfolio Manager | 2006 | 2011 |
Biography | Qi joined Acadian in November 2006. In addition to approving portfolios and working with our Marketing and Client Service Team, she is a key member of the Global Research Team. Previously, she was with State Street Global Markets, where she headed the Global Quantitative Research Team. Earlier, she led Morgan Stanley's US quantitative strategy in New York, and before that was a senior biostatistician at Merck & Co. | ||
Charles H. Wang | CEO | 2002 | 2010 |
Biography | Charles joined the E Fund Management (Hong Kong) Company Limited (“E Fund”) in July 2010 as Chief Executive Officer. He is responsible for E Fund’s overall global investments and global business expansions. Prior to joining E Fund, Charles served as Director of Research & Senior Portfolio Manager at Acadian Asset Management, a leading institutional global investment manager headquartered in Boston with total assets under management of over US$50 billion. Charles was directly responsible for Acadian’s global emerging markets strategy, which aggregated US$12 billion in assets under management, including the Acadian Emerging Markets Fund (ticker: AEMGX), which was ranked number 1 by Lipper (on a cumulative performance basis) among diversified emerging markets funds in the US for the 10-year period ending 2009. | ||
Matthew G. Cohen | Managing Director | 2005 | 2010 |
Biography | Matthew G. Cohen, M.D., managing director, is a research analyst in the U.S. Equity Group. An employee since 2005, Dr. Cohen has been portfolio manager since 2015 and a research analyst in the firm’s U.S. Equity Group since 2005. Before joining the firm, Matthew was a senior healthcare analyst at Medici Healthcare and a senior analyst covering medical products at Narragansett Asset Management, a New York-based healthcare hedge fund. Prior to that, Dr. Cohen was a resident surgeon in the Department of General Surgery at the North Shore University Hospital NYU School of Medicine. Matthew holds an M.B.A. from New York University Stern School of Business and an M.D. from McGill University in Montreal. |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review